Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Change in Account Payables (2022 - 2025)

Envoy Medical's Change in Account Payables history spans 4 years, with the latest figure at $412000.0 for Q4 2025.

  • Quarterly results put Change in Account Payables at $412000.0 for Q4 2025, up 285.59% from a year ago — trailing twelve months through Dec 2025 was $1.4 million (up 7389.47% YoY), and the annual figure for FY2025 was $1.4 million, up 7389.47%.
  • Change in Account Payables for Q4 2025 was $412000.0 at Envoy Medical, down from $1.0 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $1.4 million in Q2 2023 to a low of -$1.8 million in Q4 2023.
  • The 4-year median for Change in Account Payables is $104078.5 (2022), against an average of $119437.5.
  • The sharpest move saw Change in Account Payables skyrocketed 509.68% in 2023, then plummeted 3273.68% in 2024.
  • Year by year, Change in Account Payables stood at $235000.0 in 2022, then crashed by 877.45% to -$1.8 million in 2023, then surged by 87.85% to -$222000.0 in 2024, then skyrocketed by 285.59% to $412000.0 in 2025.
  • According to Business Quant data, Change in Account Payables over the past three periods came in at $412000.0, $1.0 million, and -$43000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.